Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(5)
•••
alexmed95
X
View Profile
View Bullboard History
Comment by
alexmed95
on Feb 21, 2021 6:09pm
RE:VR is out
yup, can't blame them haha. Like Europe said, the opportunity cost is high as F in this company. For real, It was a giant waste of time for 99% of my time invested. I think 2021 we be my last
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Feb 20, 2021 7:38pm
VR is out
Correct me if wrong - according to morninstar VR dumped 100% position in Dec/20. ouch.
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(2)
•••
europe10
X
View Profile
View Bullboard History
Post by
europe10
on Feb 18, 2021 11:32am
to clarify
I wrote one of my worst investments, in that I include the opportunity cost. No real loss but so many years without any visible return while markets have climbed and climbed, specially in their
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Comment by
europe10
on Feb 18, 2021 11:29am
RE:How Low Do We GO
IMV has no IR When an institutional player gets involved we get a climb in the stock price like in end Jan/beginning Feb.When they are filled stock price goes back down again Expect only a short spike
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Feb 18, 2021 10:30am
How Low Do We GO
In the absence of news, looks like we could drop to around $3.80. If they fail to meet expectations with any of the scheduled updates this quarter,look out below.Let's hope they can have some
...more
(1)
•••
TheHammer
X
View Profile
View Bullboard History
Post by
TheHammer
on Feb 18, 2021 7:19am
article out yesterday on DPX Survivac
See attached article link to copy and paste into your browser: https://www.drugdiscoverytrends.com/qa-why-imvs-dpx-survivac-shows-promise-in-treating-ovarian-cancer/
(17)
•••
alphaseeking001
X
View Profile
View Bullboard History
Post by
alphaseeking001
on Feb 17, 2021 12:50pm
Hmm. Weird trading.
Strange trading the past week... All that buying and now selling. There's a big, likely phantom block of shares on the ask at 4.89... seems to be trying to put a cap on things. Oh well
...more
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Feb 17, 2021 10:46am
RE:RE:RE:RE:RE:RE:Any thoughts on the past week’s trading?
Like many others of us...I think, I frequently send an email to Pierre. He always gives a reply. It is a waiting game and yes DLBCL meeting with FDA is this month. I dont know the exact date.
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Feb 17, 2021 9:52am
RE:RE:RE:RE:RE:Any thoughts on the past week’s trading?
This is a very hard investment to keep in one's portfolio and many times I have resisted the urge to sell.What really is troubling is their inability to meet expectations,delay after delay.The
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Feb 16, 2021 1:56pm
IR status...
is IMV at stage to carry full time IR ppl? or just contracted promoter? seems they're busy with something else...
(17)
•••
alphaseeking001
X
View Profile
View Bullboard History
Comment by
alphaseeking001
on Feb 16, 2021 6:13am
RE:RE:RE:RE:RE:Any thoughts on the past week’s trading?
Thanks for the reply Europe. Hoping we get truly solidly good news soon. Like you, I got caught up a bit too much in IMV years ago. I do feel their oncology program seems to be
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Comment by
europe10
on Feb 16, 2021 3:26am
RE:RE:RE:RE:Any thoughts on the past week’s trading?
When looking at the price/volume action the last week's, it does very much look like a (or several) larger buyers have accumulated shares. The last day's move down might simply be that they
...more
(17)
•••
alphaseeking001
X
View Profile
View Bullboard History
Comment by
alphaseeking001
on Feb 15, 2021 5:01pm
RE:RE:Any thoughts on the past week’s trading?
Hmm. Thanks for that perspective. I guess it's hard to know if it's systemic concern for a larger market correction or whether it's a more normal pullback from a bigger move of
...more
(17)
•••
alphaseeking001
X
View Profile
View Bullboard History
Post by
alphaseeking001
on Feb 15, 2021 1:58pm
Any thoughts on the past week’s trading?
My read is that this is a healthy pullback after a good run up however as I've pointed out many times I'm no technical trader. Any thoughts on the last weeks trading?
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Feb 11, 2021 3:23pm
RE:RE:RE:RE:Outta Here...
they have a meeting with the FDA this month. Fred told that on the fireside chat last month. I hope Fred will partner with Merck, a deal like this is possible. The biomarker is the dealmaker. https:
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >